Search Results

There are 56797 results for: content related to: Expanding Nilotinib Access in Clinical Trials (ENACT)

  1. You have free access to this content
    Practical management of patients with chronic myeloid leukemia

    Cancer

    Volume 117, Issue 19, 1 October 2011, Pages: 4343–4354, Francisco Cervantes and Michael Mauro

    Version of Record online : 16 MAR 2011, DOI: 10.1002/cncr.26062

  2. You have free access to this content
    Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia

    Cancer

    Volume 118, Issue 2, 15 January 2012, Pages: 300–311, Jerald P. Radich

    Version of Record online : 29 JUN 2011, DOI: 10.1002/cncr.26280

  3. Effects of Rifampin and Ketoconazole on the Pharmacokinetics of Nilotinib in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 51, Issue 1, January 2011, Pages: 75–83, Dr Chiaki Tanaka, Dr Ophelia Q. P. Yin, Dr Tom Smith, Dr Venkat Sethuraman, Ms Karen Grouss, Dr Lawrence Galitz, Dr Robert Harrell and Dr Horst Schran

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270010367428

  4. Effects of Yogurt and Applesauce on the Oral Bioavailability of Nilotinib in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 51, Issue 11, November 2011, Pages: 1580–1586, Dr Ophelia Q. P. Yin, Dr Marc Rudoltz, Dr Ivana Galetic, Dr Jeiry Filian, Dr Arun Krishna, Dr Wei Zhou, Dr Joseph Custodio, Dr Georg Golor and Dr Horst Schran

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010384116

  5. You have full text access to this OnlineOpen article
    Suboptimal responses in chronic myeloid leukemia

    Cancer

    Volume 118, Issue 5, 1 March 2012, Pages: 1181–1191, Elias Jabbour, Giuseppe Saglio, Timothy P. Hughes and Hagop Kantarjian

    Version of Record online : 28 OCT 2011, DOI: 10.1002/cncr.26391

  6. Current and Future Clinical Strategies in the Management of Chronic Myeloid Leukemia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 9P2, September 2010, Pages: 77S–101S, Kamakshi V. Rao, Andrea Iannucci and Elias Jabbour

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.30.pt2.77S

  7. Inhibitory effect of single and repeated doses of nilotinib on the pharmacokinetics of CYP3A substrate midazolam

    The Journal of Clinical Pharmacology

    Volume 55, Issue 4, April 2015, Pages: 401–408, Hefei Zhang, Jennifer Sheng, Jin H. Ko, Cheng Zheng, Wei Zhou, Petra Priess, Wen Lin and Steven Novick

    Version of Record online : 27 FEB 2015, DOI: 10.1002/jcph.434

  8. You have free access to this content
    Chronic myeloid leukemia 2011: Successes, challenges, and strategies—Proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop

    American Journal of Hematology

    Volume 86, Issue 9, September 2011, Pages: 811–819, Tariq I. Mughal, Jerald P. Radich, Richard A. Van Etten, Alfonso Quintás-Cardama, Tomasz Skorski, Farhad Ravandi, Daniel J. DeAngelo, Carlo Gambacorti-Passerini, Giovanni Martinelli and Ayalew Tefferi

    Version of Record online : 17 AUG 2011, DOI: 10.1002/ajh.22097

  9. You have free access to this content
    Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome–positive acute lymphoblastic leukemia

    Cancer

    Volume 121, Issue 6, March 15, 2015, Pages: 863–871, Avichai Shimoni, Yulia Volchek, Maya Koren-Michowitz, Nira Varda-Bloom, Raz Somech, Noga Shem-Tov, Ronit Yerushalmi and Arnon Nagler

    Version of Record online : 11 NOV 2014, DOI: 10.1002/cncr.29141

  10. You have free access to this content
    Evaluation of residual CD34+Ph+ progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy

    Cancer

    Volume 118, Issue 21, 1 November 2012, Pages: 5265–5269, Marzia Defina, Micaela Ippoliti, Alessandro Gozzetti, Elisabetta Abruzzese, Fausto Castagnetti, Rosaria Crupi, Mario Tiribelli, Massimo Breccia, Marzia Salvucci, Lara Aprile, Claudia Baratè, Antonella Gozzini, Gianantonio Rosti, Francesco Lauria and Monica Bocchia

    Version of Record online : 19 APR 2012, DOI: 10.1002/cncr.27506

  11. Nilotinib: A New Tyrosine Kinase Inhibitor for the Treatment of Chronic Myelogenous Leukemia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 11, November 2008, Pages: 1374–1382, Anthony Jarkowski and Richard P. Sweeney

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.11.1374

  12. Clinical Pharmacokinetics of the BCR–ABL Tyrosine Kinase Inhibitor Nilotinib

    Clinical Pharmacology & Therapeutics

    Volume 87, Issue 2, February 2010, Pages: 197–203, C Tanaka, O Q P Yin, V Sethuraman, T Smith, X Wang, K Grouss, H Kantarjian, F Giles, O G Ottmann, L Galitz and H Schran

    Version of Record online : 18 NOV 2009, DOI: 10.1038/clpt.2009.208

  13. You have free access to this content
    Developmental Therapeutics Consortium report on study design effects on trial outcomes in chronic myeloid leukaemia

    European Journal of Clinical Investigation

    Volume 42, Issue 9, September 2012, Pages: 1016–1026, Francis Giles, François-Xavier Mahon, Bjorn Gjertsen, Ronan Swords, Boris Labar, Anna Turkina and Gianantonio Rosti

    Version of Record online : 1 MAY 2012, DOI: 10.1111/j.1365-2362.2012.02675.x

  14. You have free access to this content
    Activity and tolerability of nilotinib

    Cancer

    Volume 116, Issue 19, 1 October 2010, Pages: 4564–4572, Maya Koren-Michowitz, Philipp le Coutre, Justus Duyster, Christof Scheid, Panayiotis Panayiotidis, Witold Prejzner, Jacob M. Rowe, Michaela Schwarz, Neta Goldschmidt and Arnon Nagler

    Version of Record online : 19 AUG 2010, DOI: 10.1002/cncr.25351

  15. Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: An insight

    Clinical and Experimental Pharmacology and Physiology

    Volume 41, Issue 10, October 2014, Pages: 788–797, Gamal E Shiha, Nashwa M Abu-Elsaad, Khaled R Zalata and Tarek M Ibrahim

    Version of Record online : 30 OCT 2014, DOI: 10.1111/1440-1681.12286

  16. You have free access to this content
    Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management

    American Journal of Hematology

    Volume 87, Issue 11, November 2012, Pages: 1037–1045, Elias Jabbour and Hagop Kantarjian

    Version of Record online : 23 OCT 2012, DOI: 10.1002/ajh.23282

  17. You have free access to this content
    Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase: Importance of achieving treatment-free remission

    American Journal of Hematology

    Volume 90, Issue 3, March 2015, Pages: 242–249, Harry P. Erba

    Version of Record online : 30 JAN 2015, DOI: 10.1002/ajh.23902

  18. Effect of the Proton Pump Inhibitor Esomeprazole on the Oral Absorption and Pharmacokinetics of Nilotinib

    The Journal of Clinical Pharmacology

    Volume 50, Issue 8, August 2010, Pages: 960–967, Dr Ophelia Q. P. Yin, Dr Neil Gallagher, Dr Deirdre Fischer, Dr Eren Demirhan, Dr Wei Zhou, Dr Georg Golor and Dr Horst Schran

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009346061

  19. You have free access to this content
    Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia

    British Journal of Haematology

    Volume 150, Issue 3, August 2010, Pages: 303–312, Fabio P. S. Santos, Hagop Kantarjian, Carmen Fava, Susan O’Brien, Guillermo Garcia-Manero, Farhad Ravandi, William Wierda, Deborah Thomas, Jianquin Shan and Jorge Cortes

    Version of Record online : 10 JUN 2010, DOI: 10.1111/j.1365-2141.2010.08245.x

    Corrected by:

    Corrigendum

    Vol. 155, Issue 3, 409, Version of Record online: 11 OCT 2011

  20. Safety profiles of second-line tyrosine kinase inhibitors in patients with chronic myeloid leukaemia

    Journal of Clinical Nursing

    Volume 19, Issue 9-10, May 2010, Pages: 1207–1218, Sara M Tinsley

    Version of Record online : 16 MAR 2010, DOI: 10.1111/j.1365-2702.2009.03167.x